Two Sigma Investments »

Achilles Therapeutics shares owned by Two Sigma Investments

Quarter-by-quarter ownership of Achilles Therapeutics (ACHL) shares owned by Two Sigma Investments from 13F filings

Historical chart of Two Sigma Investments investment in Achilles Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Achilles Therapeutics held by Two Sigma Investments consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Achilles Therapeutics by Two Sigma Investments

Quarter filed Position value Share count Share price at filing
2024-06-30 $18k 22k 0.82
2024-03-31 $15k 12k 1.25

More positions owned by Two Sigma Investments

Spdr S&p 500 Etf Tr Tr Unit Call Option (SPY)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Carnival Corp Unit 99/99/9999 Put Option (CCL)
Apple Call Option (AAPL)
Microsoft Corporation Call Option (MSFT)
Meta Platforms Cl A (META)
Carvana Cl A (CVNA)
Snowflake Cl A (SNOW)
Bristol Myers Squibb (BMY)
Visa Com Cl A (V)
Costco Wholesale Corporation (COST)
Abbott Laboratories (ABT)
Amazon (AMZN)
Robinhood Mkts Com Cl A (HOOD)
Uber Technologies Put Option (UBER)

View all positions for Two Sigma Investments

Top funds holding Achilles Therapeutics

Syncona Portfolio
BML Capital Management
Fcpm Iii Services B.v.
Redmile Group
Vestal Point Capital
Ikarian Capital
Siren
Renaissance Technologies
Acadian Asset Management
Two Sigma Advisers
Geode Capital Management
Two Sigma Investments
Corsair Capital Management
Baader Bank
Susquehanna International

View all funds holding Achilles Therapeutics